Ecolab Life Sciences to showcase bioquell qube and more at BIO 2024
BPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we are delighted to share our innovative modular rapid...
Inceptua expands early access program for cefiderocol in Latin America
While antimicrobial resistance is on the rise, a greater number of people still succumb to infections caused by drug-sensitive bacteria. The study reveals that ongoing...
Elinzanetant shows significant reduction in menopausal hot flushes
Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical & Scientific Meeting in San Francisco. The studies...
New drug offers safer, non-toxic alternative for pain relief
The drug, SRP-001’s promising results from its phase 1 trial were also published. The announcement was made by South Rampart Pharma Inc. and the study...
Showcasing innovation in cell line development technology
BPR: What new products or innovations is Abzena showcasing at BIO 2024 this year? Abzena has recently launched our AbZelect and AbZelectPRO cell line development (CLD)...
Study highlights lack of awareness of cholesterol-related cardiac risks
Presented at ISPOR 2024, the findings emphasize the need for integrating patient needs and preferences into strategies for managing unhealthy cholesterol (low-density lipoprotein cholesterol or...
Roquette’s new capsules – solving drug delivery issues
The company says its new product, built on its advanced Lycagel pea starch technology, offers manufacturers the freedom to select the optimal plasticizer combination, customizing...
Oral drug for kidney disease launched in China by Everest Medicine
This official launch marks a significant advancement in patient care in mainland China, introducing a new era in the treatment of IgA nephropathy (IgAN). IgA nephropathy...
Sanofi’s billion euro investment in France
This move is part of a larger €3.5 billion program within the country. The investment will be allocated to facilities in Vitry-sur-Seine in Val de...
AI platform to be used in fight against cancer
Brian Hashemi, executive chairman and CEO of Novigenix, and Sabine Tejpar, founder of the IMMUcan Consortium, are leading this collaborative effort aimed at driving groundbreaking...